Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach
Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced...
"GENESIS: Contemporary Installation Art Journey" Unveiled at GalaxyArt at Galaxy Macau Integrated Resort
Celebrating the season of new beginnings, Galaxy Macau collaborates with the Macau Artist Society on an inspiring exhibition showcasing the contemporary installation art of three emerging artists from Macau MACAU, Feb. 2, 2024 /PRNewswire/ -- Galaxy...